Nested Therapeutics launches with $125m for precision cancer therapies; The Cambridge startup is mapping genetic mutations in 3D to uncover commonalities between seemingly rare causes of the disease.

Press/Media

Period7 Oct 2022

Media coverage

1

Media coverage